These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 32411761)
1. Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC. Zhao S; Zhang T; Li H; Wang M; Xu K; Zheng D; Du X; Liu L Ann Transl Med; 2020 Apr; 8(8):538. PubMed ID: 32411761 [TBL] [Abstract][Full Text] [Related]
2. Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC. Zhao S; Wang M; Yang Z; Tan K; Zheng D; Du X; Liu L Ann Transl Med; 2020 Apr; 8(8):539. PubMed ID: 32411762 [TBL] [Abstract][Full Text] [Related]
3. Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma. Wang Z; Fan Q; Wang M; Wang E; Li H; Liu L Ann Transl Med; 2020 Apr; 8(8):537. PubMed ID: 32411760 [TBL] [Abstract][Full Text] [Related]
4. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization. Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739 [TBL] [Abstract][Full Text] [Related]
5. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment. Hu K; Yuan J; Tang B; Zhang F; Lu S; Chen R; Zhang L; Ren Z; Yin X Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization. Liu Y; Cheng C; Zhou H; Hu S; Wang H; Xie Q; Lei L; Wang P; Liu G; Hu H Bull Cancer; 2021 Oct; 108(10):931-939. PubMed ID: 34247763 [TBL] [Abstract][Full Text] [Related]
7. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy. Cai XR; Chen ZH; Liu MM; Lin JX; Zhang XP; Chen J; Lin Q; Ma XK; Wen JY; Xie SD; Wu XY; Dong M J Cancer; 2018; 9(13):2380-2388. PubMed ID: 30026834 [No Abstract] [Full Text] [Related]
8. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma. Young LB; Tabrizian P; Sung J; Biederman D; Bishay VL; Ranade M; Patel RS; Nowakowski FS; Fischman AM; Lookstein RA; Kim E J Vasc Interv Radiol; 2022 May; 33(5):510-517.e1. PubMed ID: 35150838 [TBL] [Abstract][Full Text] [Related]
9. Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic. Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Michitaka K; Deguchi A; Ishikawa T; Imai M; Ochi H; Joko K; Shimada N; Tajiri K; Hirooka M; Koizumi Y; Hiasa Y; Tanaka J J Gastroenterol Hepatol; 2019 Jun; 34(6):1066-1073. PubMed ID: 30549320 [TBL] [Abstract][Full Text] [Related]
10. ALBI and P-ALBI grade in Child-Pugh A patients treated with drug eluting embolic chemoembolization for hepatocellular carcinoma. Carling U; Røsok B; Line PD; Dorenberg EJ Acta Radiol; 2019 Jun; 60(6):702-709. PubMed ID: 30205701 [TBL] [Abstract][Full Text] [Related]
11. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation. Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408 [No Abstract] [Full Text] [Related]
12. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724 [TBL] [Abstract][Full Text] [Related]
14. ASARA, a prediction model based on Child-Pugh class in hepatocellular carcinoma patients undergoing transarterial chemoembolization. Jia KF; Wang H; Yu CL; Yin WL; Zhang XD; Wang F; Sun C; Shen W Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):490-497. PubMed ID: 35260337 [TBL] [Abstract][Full Text] [Related]
15. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT). Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502 [TBL] [Abstract][Full Text] [Related]
16. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study. Lee SK; Song MJ; Kim SH; Park M PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923 [TBL] [Abstract][Full Text] [Related]
17. Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy. Su TS; Yang HM; Zhou Y; Huang Y; Liang P; Cheng T; Chen L; Li LQ; Liang SX Radiat Oncol; 2019 Mar; 14(1):50. PubMed ID: 30917853 [TBL] [Abstract][Full Text] [Related]
18. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma. Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815 [TBL] [Abstract][Full Text] [Related]
19. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Wang YY; Zhong JH; Su ZY; Huang JF; Lu SD; Xiang BD; Ma L; Qi LN; Ou BN; Li LQ Br J Surg; 2016 May; 103(6):725-734. PubMed ID: 27005482 [TBL] [Abstract][Full Text] [Related]
20. Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis. Hiraoka A; Kumada T; Kudo M; Hirooka M; Koizumi Y; Hiasa Y; Tajiri K; Toyoda H; Tada T; Ochi H; Joko K; Shimada N; Deguchi A; Ishikawa T; Imai M; Tsuji K; Michitaka K; Dig Dis; 2017; 35(6):602-610. PubMed ID: 29040999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]